Redburn Atlantic Initiates Coverage On Tandem Diabetes Care With Buy Rating, Announces Price Target of $60
Redburn Atlantic Initiates Coverage On Tandem Diabetes Care With Buy Rating, Announces Price Target of $60
Redburn Atlantic以買入評級啓動Tandem糖尿病護理保險，宣佈目標股價爲60美元
Redburn Atlantic analyst Issie Kirby initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Buy rating and announces Price Target of $60.
雷德本大西洋分析師伊西·柯比以買入評級啓動了對Tandem Diabetes Care（納斯達克股票代碼：TNDM）的報道，並宣佈目標股價爲60美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。